In colon cancer cells, Urolithin A significantly enhanced the expression of cytochrome c and elevated the levels of caspase-3 and caspase-9 in a dose-responsive way, with the stimulation of caspase-3 and caspase-9 in the cytoplasmic lysate potentially triggering apoptotic processes [290]. Here, CASP9 is linked to colonic neoplasm.